
Ion Exchange (India) Ltd Q1 FY27 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
Yes
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- →Expect 20% year-on-year consolidated operating income growth (INR 701 crores in Q1 FY27).
- →Specialty chemicals segment revenue projected to increase substantially, with Roha plant utilization and capacity expansions driving growth (potential 50% increase over next 2 years).
- →Resin capacity expected to expand up to 5x through Roha and Ankleshwar expansions, targeting a larger global market share.
- →Treatment solutions segment focused on higher-value, advanced technology projects like resource recovery, hydrogen, ultra-pure water, and lithium extraction for medium to long-term growth.
- →Lifecycle services and industrial products segments showing healthy growth, with lifecycle services growing 28% YoY and industrial products by 14% YoY.
- →New contracts (e.g., Hyundai, Petroleum Development Oman) and geographic expansion, especially in North America and overseas markets, expected to boost revenues.
- →Bid pipeline strong at INR 9,777 crores, indicating healthy future order inflows.
- →Strategic focus on repeatable, less capital-intensive business models like O&M and BOO/BOOT expected to improve revenue predictability.
Margin guidance
Category 3- →Company expects a clear path to restoring double-digit profitability over time, despite near-term pressures from legacy projects and geopolitical factors.
- →Specialty chemicals segment projected to improve margins as Roha plant stabilizes and capacity utilization rises; potential for at least 50% capacity increase.
- →Treatment solutions business focusing on advanced, high-tech projects (e.g., resource recovery, hydrogen, ultra-pure water) to improve profitability and mix in medium to longer term.
- →Lifecycle services and industrial products segments are growing, with healthy order book and strong bid pipeline supporting future revenue growth.
- →Expect gradual quarter-on-quarter improvement in profitability, though full recovery to previous high margins may take time due to legacy contract overhang.
- →Investments in global market expansion (e.g., Americas with WQA certification) anticipated to drive incremental revenue growth.
- →Focus on asset-light growth in BOO/BOOT contracts to improve free cash flow conversion and reduce working capital pressure.
Fundraise plans
- →The transcript on page 34 and surrounding pages does not mention any current or planned fundraising through debt or equity.
- →The management discusses ongoing projects, legacy contracts, and business segments but no references to new debt or equity raising.
- →Focus is on improving profitability and executing existing projects with careful capital management.
- →No explicit comments on raising capital or new financial instruments were made during the Q&A or closing remarks.
Order book
Yes- →As of June 2026, the total order backlog was approximately INR 2,473 crores.
- →The unexecuted portion of the UP government-driven project is around 11% of this backlog.
- →A significant part of a large legacy project (excluding UP) is behind completion, with a sizable portion still remaining.
- →Management expects a significant part of the large legacy project's work to be completed in the financial year 2027, but full closure may span into the next financial year, due to funding flows.
- →Newer, more profitable projects like Hyundai contract are being added to offset legacy project impacts.
- →Overall, the company remains fully mobilized and focused on execution but is cautious about increasing receivables without assured fund inflows.
Capex plans
Yes- →Significant capacity expansion is underway at the Roha and Ankleshwar plants, aiming for approximately 5x the original resin capacity post expansion and de-bottlenecking.
- →Phase I (Roha expansion) will double resin capacity; Phase II along with de-bottlenecking will reach 5x total output.
- →Investment focus on advanced technologies in the treatment solutions business, including resource recovery, water electrolysis, lithium extraction, ultra-pure water, and high-purity water solutions.
- →Strategic investments to strengthen presence in global markets, such as obtaining WQA certification for Americas market and appointing regional leadership across Americas, Asia Pacific, Middle East Africa, and Europe.
- →Focus on asset-light models in BOT/BOOT projects, balancing capital intensity and better margin profiles.
- →Capital allocation cautious, selective approach in project bidding to manage exposure and ensure profitability.
- →Ongoing investments in resins, membranes (including new plants), and specialty chemicals portfolios to drive growth.
Track Ion Exchange (India) Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- →Company expects a clear path to restoring double-digit profitability over time, despite near-term pressures from legacy projects and geopolitical factors.
- →Specialty chemicals segment projected to improve margins as Roha plant stabilizes and capacity utilization rises; potential for at least 50% capacity increase.
- →Treatment solutions business focusing on advanced, high-tech projects (e.g., resource recovery, hydrogen, ultra-pure water) to improve profitability and mix in medium to longer term.
- →Lifecycle services and industrial products segments are growing, with healthy order book and strong bid pipeline supporting future revenue growth.
- →Expect gradual quarter-on-quarter improvement in profitability, though full recovery to previous high margins may take time due to legacy contract overhang.
- →Investments in global market expansion (e.g., Americas with WQA certification) anticipated to drive incremental revenue growth.
- →Focus on asset-light growth in BOO/BOOT contracts to improve free cash flow conversion and reduce working capital pressure.
Order book
Yes- →As of June 2026, the total order backlog was approximately INR 2,473 crores.
- →The unexecuted portion of the UP government-driven project is around 11% of this backlog.
- →A significant part of a large legacy project (excluding UP) is behind completion, with a sizable portion still remaining.
- →Management expects a significant part of the large legacy project's work to be completed in the financial year 2027, but full closure may span into the next financial year, due to funding flows.
- →Newer, more profitable projects like Hyundai contract are being added to offset legacy project impacts.
- →Overall, the company remains fully mobilized and focused on execution but is cautious about increasing receivables without assured fund inflows.
How does Ion Exchange (India) Ltd rank vs peers in Other Utilities?
Pro featureSee full Other Utilities sector rankings
How does Ion Exchange (India) Ltd rank in Other Utilities?
Compare Ion Exchange (India) Ltd against every Other Utilities company (Q1 FY27) on revenue, margins and earnings-call signals.